Prazosin for Agitation in Alzheimer's Disease
Public ClinicalTrials.gov record NCT03710642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prazosin for Disruptive Agitation in Alzheimer's Disease (AD) (PEACE-AD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease. Two thirds of the participants will participate in the medication portion, while one third will participate in the placebo portion
Study identification
- NCT ID
- NCT03710642
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2018 (Actual)
- Primary completion
- Jan 5, 2022 (Actual)
- Completion
- Jan 5, 2022 (Actual)
- Last update posted
- Feb 6, 2023
2018 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| University of California, San Diego (UCSD) | San Diego | California | 92093 | — |
| Alta California Medical Group | Simi Valley | California | 93065 | — |
| Stanford University | Stanford | California | 94305 | — |
| University of Kentucky | Lexington | Kentucky | 40506 | — |
| Northern Light/Acadia Hospital Eastern Maine Medical Center | Bangor | Maine | 04401 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| VAMC: James J Peters | The Bronx | New York | 10468 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Roper St. Francis Hospital | Charleston | South Carolina | 29401 | — |
| University of Texas, Health Science Center San Antonio | San Antonio | Texas | 78229 | — |
| University of Washington | Seattle | Washington | 98104-2499 | — |
| University of Washington | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03710642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2023 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03710642 live on ClinicalTrials.gov.